Aubrey de Grey – How close are we to robust mouse rejuvenation, and why does that matter?
Polymath and trailblazer in bio-rejuvenation Aubrey de Grey gave a talk at Future Day 2026 on the next phase of robust mouse rejuvenation trials!
Synopsis: The “damage repair” approach to bringing aging under medical control has made huge strides since I first proposed it 25 years ago. However, since it is a divide-and-conquer strategy, we should not be surprised at the absence of progress in the “bottom line” of life extension, even in mice. Can we realistically expect that to change any time soon? I will present reasons to believe that we can, in the form of accelerating progress in proofs of efficacy of individual treatments, together with initial proof of concept that combining damage repair modalities will give additive benefits.
Aubrey de Grey, PhD Founder, President and Chief Science Officer of LEV Foundation
Dr. Aubrey de Grey is a biomedical gerontologist based in Silicon Valley, California, USA, and is the founder, President and Chief Science Officer of LEV Foundation, a biomedical research and advocacy charity focused on repairing the molecular and cellular damage of aging. He received his BA in computer science and Ph.D. in biology from the University of Cambridge.
His research interests encompass the characterisation of all the types of damage that constitute mammalian aging and the design of interventions to repair and/or obviate that damage. Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organizations. He is a highly sought-after speaker who gives frequent invited talks at scientific conferences, universities, companies in areas ranging from pharma to life insurance, and to the public.
